Influenza is the virus responsible for the disease that has its name, and it is contageous. This virus can be deadly to a greater degree when the virus creates a pandemic, which occured in the United States and other parts of the world less than 100 years ago. Other influenza pandemics primarily have occurred in countries in Asia.
That pandemic caused around a half a million deaths in the United States alone. This event is now known as the Great Influenza Epidemic. Understandably there was panic among people worldwide, as the influenza virus itself was not identified until the year 1933, so the mystery was rather frightening of what was happening at that time. The etiology for the deaths that were occuring were a complete mystery to everyone.
Clearly, at times these influenza viruses are more dangerous than others, and this was one of the strains that was most toxic during that particular epidemic. Presently, influenza is once again a very concerning sub-microscopic infectious agent, and we are their potential hosts in order for these viruses to survive.
The potentially deadly effects of Influenza is caused by this virus penetrating a host, which could be a human or an animal. Once infected and established in the host, the virus replicates within the cell of the host in the cell’s cytoplasm. To survive, the influenza virus targets an enzyme called polymerase, which is what directs the content of this cell to produce proteins the virus needs to survive.
Virus is a Latin word, meaning ‘poison’. A virus is more of a very well organized molecular parasite than an actual life form, such as bacteria. The virus cannot grow or reproduce without a host cell. That means it needs a bird or mammal, such as humans, in order to exist and thrive. And the virus has the potential to completely destroy the host in the process in order to exist.
Unlike coryza, influenza expresses symptoms more severely, and usually lasts two weeks until one recovers who has the flu. Influenza, however, poses a danger to some with compromised immune systems, such as the chronically ill, so the risk is greater in such populations, along with women who may be pregnant during the flu season, residents of nursing homes or chronic care facilities.
If unprotected by an effective influenza vaccination with such patient populations, influenza has a greater ability to create complications such as bacterial pneumonia or encephalitis.
Symptoms of influenza usually start to express themselves symptomatically about two days or so after being infected with the virus. Over 10 percent of the population is infected with this virus every year- resulting in about 200,000 hospitalizations and nearly 40,000 deaths.
Those who do survive an influenza infection allows others to obtain antibodies from them to develop other antibodies for future viral outbreaks. The antibodies are used to produce vaccines to prevent acquisition of the damaging effects of influenza. Yet thisis only if the antibodies contained in the influenza vaccine are effective against the suspected particular influenza strains that are present during the influenza season.
Specifically, it is usually what are called strept pneumo bacteria that kill those due to an infection of influenza, ultimately. This is the type of bacteria that typically infect a person suffering from influenza who may have compromised immune systems. In these cases, the bacteria are allowed to thrive at a higher and more deadly rate. If influenza occurs in a human host, the results may be the patient acquiring a bacterial infection such as these are possible.
On average, it takes over a week for one to die after being infected by influenza that has the power to cause death in particular human populations. Pandemics such as the one that occured mentioned earlier are an influenza strain so powerful that it overkills the cells of its host. The influenza virus has this ability on occasion, and it's efficacy is dependent on its mutations that have occured that makes it more powerful than other influenza viruses.
The influenza viruses are of what are called orthomyxoviruses, which is a group or family of RNA viruses that are categorized into A, B, and C. The Influenza A virus is the one that historically has caused pandemics that have developed in the past. About eighty percent of flu cases in the U.S. are type A influenza viruses. Influenza vaccinations are the only available method of prevention at this time from the potentially deadly effects of influenza.
The flu vaccination is trivalent- meaning it contains three viral strains of suspected viruses for flu outbreaks during a particular winter season, as determined by the World Health Organization, as well as the Centers for Disease Control, and other organizations.
Yet one should keep in mind that these three strains of influenza may not even exist in a particular flu season. The vaccination is a guess, at best, yet is certainly better than the absence of a flu vaccination.
Unfortunately, the influenza vaccine administered last flu season was largely ineffective due to unsuspected strains of the virus infecting others, although about 140 million injections of this vaccine were administered, and this proved to be pointless for preventative medicine.
After giving the vaccination dose to one, it takes about 10 days for that person to build up the immunity for the disease of influenza. The months of October to December are recommended to receive this vaccine. And the vaccine is about 50 percent effective in offering protection from influenza, according to others, if one calculates the previous flu seasons with flu vaccinations.
Vaccines are a catalyst for antibody production in humans, which protect them against the virus, if the influenza virus happens to present itself within them. The influenza vaccines can be given by injection or nasally.
The flu season that is now occurring was supplied with 150 million vaccines in the United States. However, some studies have shown that this vaccine is rather ineffective based on incidences of the acquisition of the influenza virus by others, initial reports have indicated.
The influenza season peaks between the months of January and March. The vaccine for this influenza season is manufactured by 6 different companies in preparation for this timeframe of the influenza season. Also, it takes manufacturers about 6 months to make and formulate the influenza vaccination.
The influenza vaccine is produced every year according to which type of virus types that may be prevalent during a particular flu season. The presence of influenza can be widespread in certain states, yet not others. The vaccination is recommended to be administered to those who are at high risk, such as the chronically ill.
Also, it is recommended that those under 18 years of age get the vaccine, as well as those people over the age of 50. Pregnant women should receive the vaccine, Health care personnel are always encouraged to get a flu vaccine as well. Such populations of those recommended to receive the flu vaccination are those believed to need the protection the vaccine may offer the most. This is of concern, as influenza can progress rapidly into the more serious illnesses mentioned earlier that can lead to death.
This season’s first influenza case was identified in Delaware in November of 2008, and it was a type B influenza strain. as there are many vaccines available to hopefully prevent this potentially dangerous viral disease in this form.
Anti-virals, on the other hand, decrease greatly the ability for viruses to reproduce once established in a human. That seems like it should be a focus during viral seasons instead of any vaccination that exist today regarding the disease of influenza. Yet, as with antibiotics, viruses can become resistant to anti-virals as well.
Yet the strains chosen for the influenza vaccine contain what are speculated influenza viruses. So the vaccine is ineffective if a new and dominant influenza viral strain that possibly could cause a pandemic happens to be present during an influenza season
With the influenza virus, again it can have the ability to kill mammals, as well as birds. The concern that there is an influenza strain that exists that has the ability to mutate, and have the ability to be shared between to sepearate life forms, and multiply within each one of them with ease. This is the case with what is known as the Avian Flu.
The most recent avian influenza virus was identified in China in 1997. Called the H5N1 virus subtype, it has the potential to be the next flu pandemic. The virus responsible for the pandemic mentioned earlier was an avian influenza, which was called the H1N1 influenza virus.
This virus, unlike the human influenza virus, has a longer incubation period- about 5 days. Also, H5N1 has the ability to mutate more rapidly, as well as replicate at a similar speed. Avian influenza viruses are highly pathogenic. No one fully understands the influenza virus and its rapid ability to mutate.
This is because this particularly malicious virus is the result of two separate influenza viruses acquiring the same host at the same time. As a result of mutual sharing of genetic material between the two viruses, novel attributes are allowed to develop and create a H5N1 that obviously prove to be rather deadly.
For an influenza pandemic to occur, which means a global disease existence and presence, the virus must emerge from another species to humans without a strong immune system- as well as the ability to make more humans ill than normal due to the constant mutation of the influenza virus.
Also, the virus must be highly contagious for a pandemic to occur. This particular virus that has been identified is just that.
The H5N1 Avian influenza virus seems to have become progressively more pathogenic in the past decade, according to others. The letters H and N, by the way, stand for the antigens HA and NA-and are the letters of proteins that protrude from the viral shell.
It is these proteins that mutate so often with the influenza virus, and which is why we continue to be infected with this virus.
With the Avian Influenza existing with the H5N1 strain, millions of birds have been slaughtered due to the danger and unpredictability of this strain.
The first recorded incidence of human-to-human transmission of the H5N1 virus was believed to be in Thailand in 2004.
There have been outbreaks of Avian flu in about 15 countries in the world so far- with Indonesia being the worst. Migratory birds spread this influenza virus between continents.
The pathogenic strength of the H5N1 strain varies due to constant re-assortment or switching of genetic material between the viruses- essentially creating hybrid modifications of what it was before this occurs due to this re-assortment that makes this virus much more virulent.
So far, about 400 people worldwide have been infected with this strain- and about half have died from the infection caused by this H5N1 influenza virus. Vaccinations are being developed and reformulated constantly at this time due to the pandemic threat of the H5N1 Influenza virus.